Skip to main content

Charles River Laboratories Remaining performance obligations

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

Remaining performance obligations at Charles River Laboratories came to $675.3M at 26 Sep 2026, up 4.0% from a year earlier.

As Charles River Laboratories reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$986.0MDec 2023$920.5MMar 2024$856.6MJun 2024$803.5MSep 2024$788.5MDec 2024$781.9MMar 2025$727.3MJun 2025$649.3MSep 2025$667.1MDec 2025$702.2MMar 2026$699.9MJun 2026$675.3MSep 2026
Charles River Laboratories Remaining performance obligations, every reported period
Period endingRemaining performance obligationsChange on a yearFiled
26 Sep 2026$675.3Mup 4.0%4 Nov 2026
27 Jun 2026$699.9Mdown 3.8%5 Aug 2026
28 Mar 2026$702.2Mdown 10.2%7 May 2026
27 Dec 2025$667.1Mdown 15.4%18 Feb 2026
27 Sep 2025$649.3Mdown 19.2%5 Nov 2025
28 Jun 2025$727.3Mdown 15.1%6 Aug 2025
29 Mar 2025$781.9Mdown 15.1%7 May 2025
28 Dec 2024$788.5Mdown 20.0%19 Feb 2025
28 Sep 2024$803.5Mdown 16.1%6 Nov 2024
29 Jun 2024$856.6Mdown 16.8%7 Aug 2024
30 Mar 2024$920.5Mdown 17.3%9 May 2024
30 Dec 2023$986.0Mdown 18.0%14 Feb 2024
30 Sep 2023$957.7Mdown 16.6%8 Nov 2023
1 Jul 2023$1.0Bup 4.3%9 Aug 2023
1 Apr 2023$1.1Bup 29.6%11 May 2023
31 Dec 2022$1.2Bup 67.9%22 Feb 2023
24 Sep 2022$1.1Bup 88.4%2 Nov 2022
25 Jun 2022$987.1Mup 90.9%3 Aug 2022
26 Mar 2022$859.0Mup 145.3%4 May 2022
25 Dec 2021$716.5Mup 97.2%16 Feb 2022
25 Sep 2021$609.5Mup 61.2%3 Nov 2021
26 Jun 2021$517.0Mup 29.1%4 Aug 2021
27 Mar 2021$350.2Mup 12.3%4 May 2021
26 Dec 2020$363.2M—17 Feb 2021
26 Sep 2020$378.1M—29 Oct 2020
27 Jun 2020$400.6M—5 Aug 2020
28 Mar 2020$312.0M—7 May 2020
31 Mar 2018$73.0M—10 May 2018

Definition

Revenue under signed contracts that the company has not yet recognised: deferred revenue plus amounts it will invoice and recognise later (ASC 606). Stated at each balance-sheet date. Companies may leave out contracts of a year or less. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Charles River Laboratories: Organic revenue (change on a year) · Revenue · Cost of services provided (excluding amortization of intangible assets) revenue · Cost of products sold (excluding amortization of intangible assets) revenue · DSA revenue · RMS revenue · Manufacturing revenue · United States revenue · Europe revenue · Canada revenue · Asia Pacific revenue · financial statements

Every KPI and segment of CRL, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.